Therapeutic Asset Ratings
1,553 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Icg-Cisplatin Nanoprobe
Liver Cancer
West China Hospital
Early P1
C
(39)
Idov-Safetm
Advanced Malignant Solid Tumor of Digestive System
Peking University
Early P1
C
(39)
Ifosfamide
Anaplastic Astrocytoma of Brain
Oliver Jonas
Early P1
C
(39)
Ifosfamide
Anaplastic Oligodendroglioma
Oliver Jonas
Early P1
C
(39)
Ifosfamide
Astrocytoma
Oliver Jonas
Early P1
C
(39)
Ifosfamide
Grade II Glioma
Oliver Jonas
Early P1
C
(39)
Ifosfamide
Grade III Glioma
Oliver Jonas
Early P1
C
(39)
Ifosfamide
Aggressive NK-Cell Leukemia
New York Medical College
Early P1
C
(39)
Ifosfamide
T-Cell And NK-Cell Neoplasm
New York Medical College
Early P1
C
(39)
Ifosfamide
Oligodendroglioma of Brain
Oliver Jonas
Early P1
C
(39)
im92 car-t cells
Gastroesophageal Junction Adenocarcinoma
Beijing Immunochina Medical Science & Technology Co., Ltd.
Early P1
C
(39)
im96 car-t cells
Digestive System Neoplasm
Beijing Immunochina Medical Science & Technology Co., Ltd.
Early P1
C
(39)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
imv101 treatment
B-Cell Non-Hodgkin Lymphoma
Suzhou Immunofoco Biotechnology Co., Ltd
Early P1
C
(39)
Infusion Of Jy231
B-Cell Non-Hodgkin Lymphoma
Guangdong Second Provincial General Hospital
Early P1
C
(39)
inn805
Head And Neck Cancer
FindCure Biosciences (ZhongShan) Co., Ltd.
Early P1
C
(39)
inn805
Squamous Cell Lung Carcinoma
FindCure Biosciences (ZhongShan) Co., Ltd.
Early P1
C
(39)
inn805
Cancer
FindCure Biosciences (ZhongShan) Co., Ltd.
Early P1
C
(39)
Inno-206
Grade II Glioma
Oliver Jonas
Early P1
C
(39)
Inno-206
Grade III Glioma
Oliver Jonas
Early P1
C
(39)
Inno-206
Aggressive NK-Cell Leukemia
New York Medical College
Early P1
C
(39)
Inno-206
T-Cell And NK-Cell Neoplasm
New York Medical College
Early P1
C
(39)
Inno-206
Oligodendroglioma of Brain
Oliver Jonas
Early P1
C
(39)
Iparomlimab
DC-CIK Treatment
JIANG LONGWEI
Early P1
C
(39)
Showing 551 to 575 of 1,553 assets
Previous
Page 23 of 63
Next
